<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OALibJ</journal-id><journal-title-group><journal-title>Open Access Library Journal</journal-title></journal-title-group><issn pub-type="epub">2333-9705</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oalib.1110521</article-id><article-id pub-id-type="publisher-id">OALibJ-127968</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Business&amp;Economics</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Engineering</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject><subject> Social Sciences&amp;Humanities</subject></subj-group></article-categories><title-group><article-title>
 
 
  Clinical, Laboratory and Ultrasound Profile of Patients with Thyroid Nodules in Kinshasa
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jacques</surname><given-names>Mbizi Kumbu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aliocha</surname><given-names>Natuhoyila Nkodila</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jules</surname><given-names>Nakafwako Kuzeye</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Serge</surname><given-names>Fueza Bisuta</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dédé</surname><given-names>Tshitemb Matanda</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jacquie</surname><given-names>Bonsuani Lessenge</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jacques</surname><given-names>Aimé Bangudi Bazeboso</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Erick</surname><given-names>Matondo Matondo</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Raoul</surname><given-names>Vindu Makelele</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Oscar</surname><given-names>Eputa Mokambo</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Honoré</surname><given-names>Yambula Kiabaka</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>E.</surname><given-names>Sangwa Muyumba</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Augustin</surname><given-names>Mutsunga Kasereka</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Christophe</surname><given-names>Mulondwa Kimona</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Franck</surname><given-names>Ngoange Kasereka</given-names></name><xref ref-type="aff" rid="aff9"><sup>9</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Florent</surname><given-names>Zola Kiazayawoko</given-names></name><xref ref-type="aff" rid="aff10"><sup>10</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cynthia</surname><given-names>Bokumba Minouche</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Michel</surname><given-names>Tshikwela Lelo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Antoine</surname><given-names>Molua</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean</surname><given-names>Tshibola Mukaya</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff10"><addr-line>Department of Internal Medicine, HPGRK, Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff6"><addr-line>Department of Radiology, International Center for Advanced Medicine in Goma, North Kivu, Democratic Republic of the Congo</addr-line></aff><aff id="aff5"><addr-line>Department of Radiology, Okapia Medical Diagnostic Center, Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff9"><addr-line>RTNC Hospital Center, Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff4"><addr-line>Department of Surgery, University of Kinshasa, Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff2"><addr-line>Department of Family Medicine and Primary Health Care, Protestant University of Congo, Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff7"><addr-line>Department of Radiology, Sino-Congolese Friendship Hospital, Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff3"><addr-line>Department of Internal Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff1"><addr-line>Department of Radiology and Medical Imaging, University of Kinshasa, Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff8"><addr-line>EYANO Hospital Center in Goma, North Kivu, Democratic Republic of the Congo</addr-line></aff><pub-date pub-type="epub"><day>01</day><month>09</month><year>2023</year></pub-date><volume>10</volume><issue>09</issue><fpage>1</fpage><lpage>13</lpage><history><date date-type="received"><day>19,</day>	<month>July</month>	<year>2023</year></date><date date-type="rev-recd"><day>23,</day>	<month>September</month>	<year>2023</year>	</date><date date-type="accepted"><day>26,</day>	<month>September</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Thyroid nodule is a common disorder normally detected by ultrasound. However, little is known about the prevalence of thyroid nodules in the population of Kinshasa. The objective of this study is to determine the ultrasound profile of thyroid nodules and its characteristics in patients followed in Kinshasa hospitals. 
  Methods: This is a descriptive and cross-sectional study, based on the medical records of patients who have been operated on in hospitals in Kinshasa. All participants underwent thyroid ultrasound. The clinical and sonographic characteristics were studied. 
  Results: In total, 61 patients (mean age: 47.38 &#177; 8.8 years, 96.7% women) were included in this study. The mean clinical score of the patients was 3.4 &#177; 0.84. The majority of patients were classified as having an intermediate risk (85.2%). The majority of ultrasounds performed were indicated for anterior cervical swelling (78.7%). The majority of patients had more than three nodules (34.4%), the outline of the nodules was more regular (85.2%), they had a rounded shape in 11.5%, mostly isoechogenic echogenicity (62.3%) and a solid echostructure in 54.1%. A total of 57.4% of nodules had central vascularization and 23% calcifications. After stratification according to the EU-TIRADS score, a majority of patients were classified at stages 3 and 4 (47.5% and 34.4% respectively). 
  Conclusion: This study showed a proportion of thyroid nodules at malignant risk. Therefore, screening for thyroid nodules should be added to routine workups especially in women to improve early detection of thyroid nodules, targeting those with a high risk profile.
 
</p></abstract><kwd-group><kwd>Thyroid Nodule</kwd><kwd> Ultrasound</kwd><kwd> Profile</kwd><kwd> Kinshasa</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The thyroid nodule (TN), which is defined by any localized hypertrophy of the thyroid gland [<xref ref-type="bibr" rid="scirp.127968-ref1">1</xref>] , has become increasingly frequent in medical practice, thanks to the development of medical imaging techniques [<xref ref-type="bibr" rid="scirp.127968-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.127968-ref3">3</xref>] and the recourse to the expertise of pathologists [<xref ref-type="bibr" rid="scirp.127968-ref1">1</xref>] . The prevalence of nodules depends on the detection technique used, sex and age [<xref ref-type="bibr" rid="scirp.127968-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.127968-ref4">4</xref>] . The prevalence of clinically palpable nodules is around 5% for women and around 1% for men in countries with sufficient iodine intake such as the United States of America and England [<xref ref-type="bibr" rid="scirp.127968-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.127968-ref2">2</xref>] . This prevalence is multiplied by 10 on ultrasound examination and by 15 on autoptic examinations, thus making nodules a major public health problem [<xref ref-type="bibr" rid="scirp.127968-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.127968-ref2">2</xref>] . The occurrence of nodules and their malignant degeneration are influenced by advanced age, female sex, multiparity, external irradiation and high TSH levels [<xref ref-type="bibr" rid="scirp.127968-ref5">5</xref>] .</p><p>The problem of the management of these nodules lies in the determination of the cancerous nodules since 5% to 10% of the nodules are cancerous. The specification of the histological type guides the rest of the management, which involves surgery, supplemented as appropriate by radioactive iodine or chemotherapy or outright target therapies.</p><p>In the DRC, data on thyroid pathologies are relative and fragmentary [<xref ref-type="bibr" rid="scirp.127968-ref6">6</xref>] ; thyroid cancer is relatively uncommon; it would be detected at advanced clinical stages [<xref ref-type="bibr" rid="scirp.127968-ref7">7</xref>] . As a result, several patients benefit from surgery for its resection, of which more than half of the thyroid nodules remain benign [<xref ref-type="bibr" rid="scirp.127968-ref8">8</xref>] . Hence the implementation of ultrasound classifications (TIRADS) [<xref ref-type="bibr" rid="scirp.127968-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.127968-ref10">10</xref>] to reduce the rate of unnecessary thyroid surgeries. This study has set the objective of studying the clinical, laboratory and ultrasound profile of TN operated in Kinshasa.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>This is a cross-sectional and descriptive study that included 61 records of patients with thyroid nodules operated on at the Bibwa Initiative Plus Hospital Center (CHIP/BIBWA), at the NGALIEMA Clinic, at the Pigeon Medical-Surgical Center (CMCP) and at the Cliniques University of Kinshasa (CUK) over a period of 24 months, from June 01, 2020 to May 31, 2022. These patients had benefited from a thyroid ultrasound and an anatomopathology examination. All available records were reviewed. The sampling was exhaustive and convenient. The variables studied were those reported in the registers, namely: age, sex, biology, clinical diagnostic parameters, and ultrasound parameters.</p><p>Only cases containing all the information on the variables of interest described were retained for the final analyses. The period concerned was guided by the availability of registers in all the hospitals mentioned above.</p><p>Collection of ultrasound data</p><p>Ultrasound equipment</p><p>The ultrasound system must have: high frequency linear transducers (10 - 13 MHz) wide band, convex and sectoral (endocavity) reproducing high quality images. Doppler mode (color and pulsed) and/or elastography module. Patient in head position in hyperextension (without auricle), in dorsal decubitus.</p><sec id="s2_1"><title>2.1. Ultrasound Technique</title><p>Clinical information: Indication and old report, biology result (T3, T4 and TSH) Techniques themselves: basic ultrasound sections: transverse and longitudinal, study of the thyroid (3D biometry, echogenicity, echostructure, vascularization, calcification), nodular characterization (size, contours, shape; echostructure, echogenicity, calcification, perinodular halo EU-TIRADS), study of echopalpable glands &amp; neighboring structures trachea, esophagus, jugulocarotidian vascular pedicle (compression, deviation) and study of cervical lymph nodes; search for possible cervical lymphadenopathy (short axis and pejorative ultrasound characters). The illustrations (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref>) related to the ultrasound data are those proposed by Dr. Gilles RUSS [<xref ref-type="bibr" rid="scirp.127968-ref11">11</xref>] .</p></sec><sec id="s2_2"><title>2.2. Collection of Histopathological Data</title><p>After excision, the surgical specimens were brought to the anatomopathology laboratory of the University Clinics of Kinshasa, the Ngaliema Clinic, CHIP (BIBWA) and the LEBOMA Anatomopathology Center of Kalamu. The reading of the slides was carried out by specialists in the field. The anatomopathological diagnosis collected was recorded in the anatomopathology registers of each laboratory mentioned above.</p></sec><sec id="s2_3"><title>2.3. Statistical Analyzes</title><p>The statistical analyses of the data were carried out using Statistical Package for Social Sciences (SPSS) for Windows version 24 software. The descriptive analyses carried out are the mean and standard deviation for the quantitative data with Gaussian distribution and the absolute (n) and relative (%) frequencies for categorical data. Pearson’s Chi-square or Fisher’s exact test, as the case may be, was performed to compare the proportions (%). The Student’s t was performed to compare the means. Logistic regression was used to search for factors associated with cancerous thyroid nodules in univariate and multivariate analysis with the calculation of OR and their 95% confidence interval to estimate the degree of association. For all the tests used, the value of p &lt; 0.05 was considered as the threshold of statistical significance.</p><p>Before carrying out this study, the protocol was submitted and approved by the Ethics Committee of the School of Public Health of the University of Kinshasa Approval number: ESP/CE/078/2023. The notion of confidentiality was essential for the study, the data were collected anonymously, were only for use in writing this work.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. General Characteristics of the Study Population</title><p>The study population included 61 patients whose general characteristics are summarized in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p><xref ref-type="table" rid="table1">Table 1</xref> reports that there was a clear female predominance (96.7%) for a sex ratio of 29.5/1. The age of the patients follows a normal distribution with the extremes ranging from 21 to 80 years. The average age of these patients was 47.4 &#177; 9.9 years, the age groups of 40 - 49 years and 50 - 59 years were the most found with respective frequencies of 39.3% and 27.7%. Most of the patients had a euthyroid hormonal biological status (89.3%). The average clinical score of patients was 3.4 &#177; 0.84 with extremes ranging from 1 to 5. The majority of patients were classified as having an intermediate risk, i.e. 85.2% of cases. The high risk was found in 6.6% of patients. The risk of malignancy low clinically (85.2%), sonographically (59.0%) and histopathologically (91.2%) (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s3_2"><title>3.2. Ultrasound Characteristics of Patients</title><p>In view of this table, we note that the left thyroid lobe had a median volume of 19.5 ml, that of right thyroid lobe was 11 ml and the isthmus had a thickness of 6.5 mm. The majority of the thyroid gland had a regular outline at the left thyroid lobe (83.6%), LTD (75.4%) and isthmus (80.3%). The echostructure of the gland was mostly heterogeneous. This heterogeneity was 67.2% at the LTG level, 70.5% at the LTD level and less at the isthmic level. There is a predominance of homogeneous echostructure (50.8%). The echogenicity was mostly isoechogenic, i.e. 72.1% at the LTG level, 73.8% at the LTD level and 68.9% at the isthmus level (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Most of the nodules were located at the level of the isthmus, i.e. 37.7% of cases. The majority of patients had more than three nodules (34.4%), the outline of the nodules was more regular (85.2%), they had a rounded shape in 11.5%, mostly isoechogenic echogenicity (62.3%) and a solid echostructure in 54.1%. A total of 57.4% of the nodules had a central vascularization and 23% presented calcifications (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>In this figure, the majority of ultrasounds performed were indicated for anterior cervical swelling (78.7%), 8.2% of ultrasounds for recurrence of cervical swelling (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec><sec id="s3_3"><title>3.3. Diagnoses Made</title><p>The majority diagnosis on thyroid ultrasound was GMHTN represented at a</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> General characteristics of the study population</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >n = 61</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Mean age (year)</td><td align="center" valign="middle" >47.38 &#177; 8.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;40</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >21.3</td></tr><tr><td align="center" valign="middle" >40 - 49</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >39.3</td></tr><tr><td align="center" valign="middle" >50 - 59</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >27.9</td></tr><tr><td align="center" valign="middle" >≥60</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >11.5</td></tr><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >96.7</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >F/M ratio</td><td align="center" valign="middle" >29.5</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Biological profile</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Euthyroidism</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >83.9</td></tr><tr><td align="center" valign="middle" >Hyperthyroidism</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >11.5</td></tr><tr><td align="center" valign="middle" >Hypothyroidism</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.6</td></tr><tr><td align="center" valign="middle" >Elements constituting the clinical score</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Extreme ages &lt; 21 and &gt;65 years old</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4.9</td></tr><tr><td align="center" valign="middle" >Presence of lymphadenopathy</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >13.1</td></tr><tr><td align="center" valign="middle" >Fixed nodule</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >36.1</td></tr><tr><td align="center" valign="middle" >Painless nodule</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >91.8</td></tr><tr><td align="center" valign="middle" >Male gender</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >Signs of local compression</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >93.4</td></tr><tr><td align="center" valign="middle" >Exophthalmos</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >Cervical swelling</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >100.0</td></tr><tr><td align="center" valign="middle" >Interpretation of the clinical score</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Weak</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >85.2</td></tr><tr><td align="center" valign="middle" >Intermediate</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >8.2</td></tr><tr><td align="center" valign="middle" >Pupil</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >6.6</td></tr><tr><td align="center" valign="middle" >Ultrasound score</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Weak</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >59.0</td></tr><tr><td align="center" valign="middle" >Intermediate</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >34.4</td></tr><tr><td align="center" valign="middle" >Pupil</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >6.6</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Ultrasound characteristics of the thyroid gland</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Left thyroid lobe n = 61 (%)</th><th align="center" valign="middle" >Rigth thyroid lobe n = 61 (%)</th><th align="center" valign="middle" >Isthmus n = 61 (%)</th></tr></thead><tr><td align="center" valign="middle" >Outline</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Irregular</td><td align="center" valign="middle" >8 (13.1)</td><td align="center" valign="middle" >14 (23.0)</td><td align="center" valign="middle" >5 (8.2)</td></tr><tr><td align="center" valign="middle" >Regular</td><td align="center" valign="middle" >51 (83.6)</td><td align="center" valign="middle" >46 (75.4)</td><td align="center" valign="middle" >49 (80.3)</td></tr><tr><td align="center" valign="middle" >Unspecified</td><td align="center" valign="middle" >2 (3.3)</td><td align="center" valign="middle" >1 (1.6)</td><td align="center" valign="middle" >7 (11.5)</td></tr><tr><td align="center" valign="middle" >Echostructure</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Homogeneous</td><td align="center" valign="middle" >16 (26.2)</td><td align="center" valign="middle" >16 (26.2)</td><td align="center" valign="middle" >31 (50.8)</td></tr><tr><td align="center" valign="middle" >Heterogeneous</td><td align="center" valign="middle" >41 (67.2)</td><td align="center" valign="middle" >43 (70.5)</td><td align="center" valign="middle" >19 (31.1)</td></tr><tr><td align="center" valign="middle" >Unspecified</td><td align="center" valign="middle" >4 (6.6)</td><td align="center" valign="middle" >2 (3.3)</td><td align="center" valign="middle" >11 (18.0)</td></tr><tr><td align="center" valign="middle" >echogenicity</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hypoechoic</td><td align="center" valign="middle" >6 (9.8)</td><td align="center" valign="middle" >6 (9.8)</td><td align="center" valign="middle" >5 (8.2)</td></tr><tr><td align="center" valign="middle" >Isoechogenic</td><td align="center" valign="middle" >44 (72.1)</td><td align="center" valign="middle" >45 (73.8)</td><td align="center" valign="middle" >42 (68.9)</td></tr><tr><td align="center" valign="middle" >Hyperechoic</td><td align="center" valign="middle" >5 (8.2)</td><td align="center" valign="middle" >4 (6.6)</td><td align="center" valign="middle" >4 (6.6)</td></tr><tr><td align="center" valign="middle" >Unspecified</td><td align="center" valign="middle" >6 (9.8)</td><td align="center" valign="middle" >6 (9.8)</td><td align="center" valign="middle" >10 (16.4)</td></tr><tr><td align="center" valign="middle" >Volume</td><td align="center" valign="middle" >19.5 (6.0 - 47.0)</td><td align="center" valign="middle" >11.0 (6.0 - 31.5)</td><td align="center" valign="middle" >6.5 (4.0 - 8.0)</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Ultrasound characteristics of thyroid nodules</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Effectif (n = 61)</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Topography</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Right unilobal</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >18.0</td></tr><tr><td align="center" valign="middle" >Left unilobar</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >21.3</td></tr><tr><td align="center" valign="middle" >Isthmus</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >37.7</td></tr><tr><td align="center" valign="middle" >Bilobar</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >23.0</td></tr><tr><td align="center" valign="middle" >Nodule number</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >34.4</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >31.1</td></tr><tr><td align="center" valign="middle" >≥3</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >34.4</td></tr><tr><td align="center" valign="middle" >Outlines</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Irregular</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >14.8</td></tr><tr><td align="center" valign="middle" >Regular</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >85.2</td></tr><tr><td align="center" valign="middle" >Form</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Oval</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >88.5</td></tr><tr><td align="center" valign="middle" >Rounded</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >11.5</td></tr><tr><td align="center" valign="middle" >Echogenicity</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hypoechoic</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >19.7</td></tr><tr><td align="center" valign="middle" >Isoechogenic</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >62.3</td></tr><tr><td align="center" valign="middle" >Hyperechoic</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >18.0</td></tr><tr><td align="center" valign="middle" >Echostructure</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Solid</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >54.1</td></tr><tr><td align="center" valign="middle" >Liquid</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4.9</td></tr><tr><td align="center" valign="middle" >Mixed</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >41.0</td></tr><tr><td align="center" valign="middle" >Vascularization</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Central</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >57.4</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >42.6</td></tr><tr><td align="center" valign="middle" >Calcifications</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >77.0</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >23.0</td></tr></tbody></table></table-wrap><p>frequency of 55.7%, followed by thyroid nodules at 21.3% nodular 19.7% (<xref ref-type="table" rid="table4">Table 4</xref>)</p></sec><sec id="s3_4"><title>3.4. EU-TIRADS Score (Risk of NT Ultrasound Malignancy)</title><p>After stratification of the nodules according to the EU-TIRADS score, the majority of the patients were classified at stage 3 and 4 respectively with a frequency of 47.5% and 34.4% (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>In our series, the majority of patients were women with a sex ratio of 1H/30F. The female sex is always very represented in thyroid pathology. The hormonal hypothesis [<xref ref-type="bibr" rid="scirp.127968-ref12">12</xref>] , the drop in immunity during pregnancy, beta HCG during pregnancy acting on the same receptor with TSH and the stress suffered by women during pregnancy and in all events of genital life can justify a preponderance of the female sex in the thyroid pathology. This trend was observed in our study with 96.7%, these results are similar to those found in several African series [<xref ref-type="bibr" rid="scirp.127968-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.127968-ref14">14</xref>] and also in Western series [<xref ref-type="bibr" rid="scirp.127968-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.127968-ref16">16</xref>] .</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of patients according to ultrasound diagnoses</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Ultrasound diagnosis</th><th align="center" valign="middle" >Effectif</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >GMHTN</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >55.7</td></tr><tr><td align="center" valign="middle" >Cystic goiter</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >Nodular goiter</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >19.7</td></tr><tr><td align="center" valign="middle" >Thyroid nodule</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >21.3</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap><p>Age influences the occurrence of thyroid nodules and even malignant degeneration [<xref ref-type="bibr" rid="scirp.127968-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.127968-ref16">16</xref>] . In our study, the average age of patients with nodules is 47.4 &#177; 9.9 years. Our average age is within the limits of those found by several African authors who found an average age around 44 &#177; 3 years [<xref ref-type="bibr" rid="scirp.127968-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.127968-ref14">14</xref>] . With regard to age groups, a peak was observed, that of 40 - 49 years. In the literature and especially in Africa, nodular thyroid pathology and even thyroid cancer are pathologies that are frequent around the age of 40 [<xref ref-type="bibr" rid="scirp.127968-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.127968-ref14">14</xref>] .</p><p>This series found: 4.9% Graves’ exophthalmos, 50% dyspnoea; 47.5% dysphagia, 8.2% dysphonia and 8.2% NT with intrathoracic plunging character. Other authors may have shown these signs in their series. But the presence of these three compressive signs, namely dysphonia, dysphagia and dyspnea, would only be related to malignancy when there is not only compression but also infiltration of neighboring organs [<xref ref-type="bibr" rid="scirp.127968-ref17">17</xref>] . The plunging character would explain the seriousness of these NT whose endothoracic extensions dangerously compressed the esophagus, the trachea with corollary an asphyxia syndrome requiring emergency tracheal intubation. NTs rarely disturb thyroid function apart from toxic and hyperfunctional nodules; this was confirmed by our study. The clear predominance of patients with euthyroidism could be explained by the normal hormonal balance sought by surgeons by administering a synthetic antithyroid drug (carbimazol) before planning the operation. Normal thyroid function; a state of euthyroidism concomitant with the development of NT was also found in proportions of 89% - 93.3% in the studies by Bukasa et al. [<xref ref-type="bibr" rid="scirp.127968-ref7">7</xref>] and Mighri et al. [<xref ref-type="bibr" rid="scirp.127968-ref18">18</xref>] .</p><p>EU-TI.RADS score and risk criteria for thyroid nodule malignancy</p><p>In our series, the practitioner used more the terminology regular contours, well circumscribed or limited against or irregular, badly limited or badly circumscribed. The fuzzy contours were not mentioned by the practitioners. Gilles Russ et al. [<xref ref-type="bibr" rid="scirp.127968-ref19">19</xref>] believe that the irregular nodular contour is a criterion of malignancy. In our series, the EU-TIRADS score retained 25 NT at risk of malignancy, including 9 with irregular contours and 16 with regular contours. But after histological analysis confirmed only five malignant NT. Nodular delimitation can be difficult when the NT is isoechogenic to the glandular segment where it sits. Thus, color Doppler vascularization will help to make the demarcation by the peripheral vascular corbelling of the NT [<xref ref-type="bibr" rid="scirp.127968-ref20">20</xref>] .</p><p>The hypoechoic nature is strongly pejorative suggestive of all criteria of malignancy [<xref ref-type="bibr" rid="scirp.127968-ref19">19</xref>] . Contradictory results exist in the literature. This difference in the figures, which is sometimes too significant, would be due; to the fact that the thyroid ultrasounds were performed by several people with different sampling criteria for the population studied.</p><p>Nodular calcifications constitute a criterion of nodular malignancy. There is both a plurality of sonographers and descriptions; we found a multiplicity of terminology (micro or macro calcifications, dusty calcifications, central, mixed, diffuse, popcorn, peripheral, linear, hyper echogenic punctuations) whose exploitation was difficult. Thus we simply reported the presence or absence of nodular calcification in this study. We found only 14 calcifications associated with the risk of EU-TIRADS malignancy. Confusion would exist between micro calcifications with comet-tail artifact, microcysts which are sometimes a source of false positives; misinterpreted as papillary microcancers.</p><p>The rounded, non-oval shape (i.e. higher than wide, higher than long) is retained as a criterion for malignancy [<xref ref-type="bibr" rid="scirp.127968-ref21">21</xref>] . In our series, we found 7 rounded NT representing a risk of malignancy assessed at 28%. Our results are not in line with Roussanka D et al. [<xref ref-type="bibr" rid="scirp.127968-ref22">22</xref>] found a much higher rate of malignancy, 51.5% of malignant NT (non-oval shape) out of a total of 103 rounded NT after histological confirmation.</p><p>Nodular echostructure: in our series, we found 54.1% nothy solids, 41% mixed and 4.9% liquid. 14 (56%) mixed NT versus 11 (44%) solid NT were associated with elevated risk of EU-TIRADS malignancy for a statistically significant p of 0.061. On the other hand, no liquid NT was. These results are similar to those of Roussanka D et al. [<xref ref-type="bibr" rid="scirp.127968-ref22">22</xref>] who found no risk of malignancy among cystic NT; 30.6% for NT EU-TIRADS 5. These authors affirm that it would then be useless to recommend a diagnostic cytopuncture for this category of cystic NT without other ultrasound malignancy characteristics, Coulibaly Ali [<xref ref-type="bibr" rid="scirp.127968-ref23">23</xref>] in Ivory Coast found the same proportion for solid NTs (54.4%) but very different compared to mixed NTs (28.8%) and 16.8% for liquids. However, evacuating cytopuncture could well be considered in the event of rapid growth with the risk of compression phenomena.</p><p>Distribution of NT according to the EU-TIRADS score</p><p>In our series, it was noted a high number of patients classified at stage 3 and 4 of EU-TIRADS. The figures related to EU-TIRADS mapping found in this study and others [<xref ref-type="bibr" rid="scirp.127968-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.127968-ref23">23</xref>] are very different and sometimes contradictory; this could be explained by the sampling techniques used recognized population already sick at the start or a population referred for a cervical ultrasound for a pathology other than thyroid in which the NT was discovered by chance, the equipment used (type of probes) as well as the level of training of the sonographer, unfortunately in our developing countries there is not yet a diploma training course in thyroidology required to do thyroid diploma in thyroidology, each one making prevail his own acquired experience and the type of population (white, black, North African) with totally different genetic conditions [<xref ref-type="bibr" rid="scirp.127968-ref19">19</xref>] .</p><p>Despite the cross-sectional nature of the study constituting a limit in this study due to the lack of certain variables to assess the characters of thyroid nodules, this study, which is a first in the DRC, reports a better appreciation of the clinical characteristics of the nodules, the progress of the he paraclinical exploration and above all the generalization of anatomopathological analysis will make it possible to better detect cancers in order to reduce their morbidity and avoid useless interventions sometimes with heavy consequences.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Thyroid nodules are frequent in our series. The proportion of cancerous nodules is significant compared to the other series. It is important to do an ultrasound to already predict the malignancy of the nodule before doing the pathology examination.</p></sec><sec id="s6"><title>Acknowledgements</title><p>We would like to thank all those who, from far or near, were willing to participate in this study; all doctors from 4 hospitals in Kinshasa, who willingly approved and accompanied the data collection for this study.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></sec><sec id="s8"><title>Author’s Contributions</title><p>JMK and ANN designed and analyzed the statistical data for the study. JNK, SFB, DTM, JBL, JABB, EMM, RVM, OEM, HYK, ESM, AMK, CMK, FNK, FZK, CBM, MTL and JTM supervised the study. All authors have read and approved the final and revised version of the manuscript.</p></sec><sec id="s9"><title>Cite this paper</title><p>Kumbu, J.M., Nkodila, A.N., Kuzeye, J.N., Bisuta, S.F., Matanda, D.T., Lessenge, J.B., Bazeboso, J.A.B., Matondo, E.M., Makelele, R.V., Mokambo, O.E., Kiabaka, H.Y., Muyumba, E.S., Kasereka, A.M., Kimona, C.M., Kasereka, F.N., Kiazayawoko, F.Z., Minouche, C.B., Lelo, M.T., Molua, A. and Mukaya, J.T. (2023) Clinical, Laboratory and Ultrasound Profile of Patients with Thyroid Nodules in Kinshasa. Open Access Library Journal, 10: e10521. https://doi.org/10.4236/oalib.1110521</p></sec></body><back><ref-list><title>References</title><ref id="scirp.127968-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Wémeau, J.L., Sadoul, J.L., Herbomez, M., Monpeyssen, H., Tramalloni, J., Leteurtre, E., et al. (2011) Les recommandations de la société franaise d’endocrinologie pour la prise en charge des nodules thyroidiens. La Presse Médicale, 40, 793-826.  
https://doi.org/10.1016/j.lpm.2011.05.001</mixed-citation></ref><ref id="scirp.127968-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Leenhardt, L., Hejblum, G., Franc, B., Fediaevsky, L.D., Delbot, T., Le Guillouzic, D., et al. (1999) Indications and Limits of Ultrasound-Guided Cytology in the Management of Non Palpable Thyroid Nodules. The Journal of Clinical Endocrinology &amp; Metabolism, 84, 24-28. https://doi.org/10.1210/jcem.84.1.5418</mixed-citation></ref><ref id="scirp.127968-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Valeix, P., Zarebska, M., Bensimon, M., Cousty, C., Bertrais, S., Galan, P., et al. (2001) Ultrasonic Assessment of Thyroid Nodules, and Iodine Status of French Adults Participating in the SU.VI.MAX Study. Annales d’Endocrinologie, 62, 499-506.</mixed-citation></ref><ref id="scirp.127968-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Mazzaferri, E.L. (1993) Management of a Solitary Thyroid Nodule. The New England Journal of Medicine, 328, 553-559.  
https://doi.org/10.1056/NEJM199302253280807</mixed-citation></ref><ref id="scirp.127968-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Polyzos, S.A., Kita, M., Efstathiadou, Z., Poulakos, P., Slavakis, A., Sofianou, D., et al. (2008) Serum Thyrotropin Concentration as a Biochemical Predictor of Thyroid Malignancy in Patients Presenting with Thyroid Nodules. Journal of Cancer Research and Clinical Oncology, 134, 953-960.  
https://doi.org/10.1007/s00432-008-0373-7</mixed-citation></ref><ref id="scirp.127968-ref6"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Joseph</surname><given-names> M. </given-names></name>,<etal>et al</etal>. (<year>2018</year>)<article-title>Bidingija, Influence des facteurs géo-éthniques sur les modifications morphologiques et fonctionnelles de la thyro&amp;iuml;de au cours de la grossesse: Cas des gestantes chinoises et congolaises suivies en consultation de Médecine Interne</article-title><source> Annals of African Medicine</source><volume> 11</volume>,<fpage> e2796</fpage>-<lpage>e2804</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.127968-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Bukasa, K.J., Sabbah, N., Bayauli, P.M., Massicard, M., Bidingija, M.J., Nkodila, A., et al. (2021) Cancer de la thyro&amp;iuml;de en République Démocratique du Congo: Fréquenceet facteurs de risque. Annales d’Endocrinologie (Paris), 82, 606-612.  
https://doi.org/10.1016/j.ando.2021.09.002</mixed-citation></ref><ref id="scirp.127968-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Wemeau, J.L., Sadoul, J.L., Herbomez, et al. (2021) Recommandations de la société francaise d’endocrinologie pour la prise en charge des nodules thyroidiens.</mixed-citation></ref><ref id="scirp.127968-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Skowronska, A., Milczarek-Banach, J., Wiechno, W., et al. (2018) Accuracy of the European Thyroid Imaging Reporting and Data System (EU-TIRADS) in the Valuation of Thyroid Nodule Malignancy in Reference to the Post Surgery Histological Résultats. Polish Journal of Radiology, 83, e579-e586.  
https://doi.org/10.5114/pjr.2018.81556</mixed-citation></ref><ref id="scirp.127968-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Joseph-Augustz, J., Lin, L., Demar, M., et al. (2020) Epidemiologic, Clinical, Ultrasonographic, and Cytological Features of Thyroid Nodules in Predicting Malignancy Risk: A Retrospective Study of 442 French Afro-Caribbean Patients. International Journal of Endocrinology, 2020, Article ID: 4039290.  
https://doi.org/10.1155/2020/4039290</mixed-citation></ref><ref id="scirp.127968-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Russ, G. and Tramallon, J. (2017) Nodule Thyro&amp;iuml;dien Stratification du risque de malignité TIRADS—Elastographie DIUE 2016 Module Endocrinologie Centre de Pathologie et d’Imagerie Unité Thyro&amp;iuml;de et Tumeurs Endocrines H&amp;ocirc;pital La Pitié-Salpêtrière Université Pierre et Marie Curie—Paris VI.</mixed-citation></ref><ref id="scirp.127968-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Leenhardt, L., Ménégaux, F., Franc, B. and Hoang, C. (2005) Cancers de la thyro&amp;iuml;de. EMC-Endocrinologie, 2, 1-38. https://doi.org/10.1016/j.emcend.2004.10.003</mixed-citation></ref><ref id="scirp.127968-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Dieng, M., Cissé, M., Ndour, M.D., Konaté, I., Touré, A.O., Ka, O., Dia, A., et al. (2010) Indications et résultats des thyroidectomies réalisées au sein d’un service de chirurgie générale. A propos de 402 patients opérés Revue Africaine de Chirurgie et Spécialités, 4, 24-27. https://doi.org/10.4314/racs.v4i9.69961</mixed-citation></ref><ref id="scirp.127968-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Darre, T., Amegbor, K., Pegbessou, F., Lawson, S., et al. (2014) Profil histo-épidé-miologique des tumeurs du corps thyroIde. Médecine d’Afrique Noire, 61, 249-251.</mixed-citation></ref><ref id="scirp.127968-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Allan, C. and Krejbjerg, A. (2014) Epidemiology of Nodular Goitre. Influence of Iodine Intake. Best Practice and Research Clinical Endocrinology and Metabolism, 28, 465-479.</mixed-citation></ref><ref id="scirp.127968-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Mesele, M., Degu, G. and Gebrehiwot, H. (2014) Prevalence and Associated Factors of Goiter among Rural Children Aged 6-12 Years Old in Northwest Ethiopia, Cross-Sectional Study. BMC Public Heath, 14, Article No. 130.  
https://doi.org/10.1186/1471-2458-14-130</mixed-citation></ref><ref id="scirp.127968-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Makeieff, M., Marlier, F., Khudjadze, M., et al. (2000) Les goitres plongeants: à propos de 212 cas. Annales de Chirurgie, 125, 18-25.  
https://doi.org/10.1016/S0001-4001(00)00117-3</mixed-citation></ref><ref id="scirp.127968-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Mighri, K., Lahmar, I., Fdhila, R. and Harzallah (2007) Facteurs predictifs de malignite d’un nodule thyroidien. Journal Tunisien d’ORL et de Chirurgie Cervico-Faciale, 18, 20-24. https://doi.org/10.4314/jtdorl.v18i1.42040</mixed-citation></ref><ref id="scirp.127968-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Russ, G., Bonnema, S.J., Erdogan, M.F., Durante, C.D. and Leenhardt, L.A. (2017) European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults. European Thyroid Journal, 6, 225-237.  
https://doi.org/10.1159/000478927</mixed-citation></ref><ref id="scirp.127968-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Moon, H.J., Kwak, J.Y., Kim, M.J., Son, E.J. and Kim, E.-K. (2010) Can Vascularity at Power Doppler US Help Predict Thyroid Malignancy? Radiology, 255, 260-269.  
https://doi.org/10.1148/radiol.09091284</mixed-citation></ref><ref id="scirp.127968-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Makeieff, M., Marlier, F., Khudjadze, M., et al. (2000) Les goitres plongeants: à propos de 212 cas. Annales de Chirurgie, 125, 18-25.  
https://doi.org/10.1016/S0001-4001(00)00117-3</mixed-citation></ref><ref id="scirp.127968-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Kovatcheva, R.D., Shinkov, A.D. and Radina, S.I. (2021) évaluation des performances diagnostiques de l’EU-TIRADS dans la discrimination des nodules thyro&amp;iuml;diens bénins des malins: une étude prospective dans un centre de référence.</mixed-citation></ref><ref id="scirp.127968-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Coulibaly, A., Idrissa, G., Anhum, K., Tchimou, A.M. and Kouamé, A.R.T. (2020) Profil des nodules thyro&amp;iuml;diens à l’échographie au Centre Hospitalier et Universitaire de Yopougon (Abidjan-C&amp;ocirc;te d’Ivoire). Journal Africain de l’Imagerie Médicale, 12, 13-19.</mixed-citation></ref></ref-list></back></article>